Veracyte Inc (NASDAQ: VCYT) is 22.85% higher on its value in year-to-date trading and has touched a low of $18.61 and a high of $35.51 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The VCYT stock was last observed hovering at around $33.13 in the last trading session, with the day’s gains setting it 0.66%.
Currently trading at $33.79, the stock is 4.31% and 13.08% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.82 million and changing 2.01% at the moment leaves the stock 36.37% off its SMA200. VCYT registered 53.89% gain for a year compared to 6-month gain of 63.81%. The firm has a 50-day simple moving average (SMA 50) of $30.0905 and a 200-day simple moving average (SMA200) of $24.808075.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 11.57% loss in the last 1 month and extending the period to 3 months gives it a 57.41%, and is 1.33% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.93% over the week and 3.80% over the month.
Veracyte Inc (VCYT) has around 815 employees, a market worth around $2.60B and $399.58M in sales. Fwd P/E is 80.70. Profit margin for the company is -13.52%. Distance from 52-week low is 81.60% and -4.83% from its 52-week high. The company has generated returns on investments over the last 12 months (-4.72%).
The EPS is expected to grow by 122.17% this year
343.0 institutions hold shares in Veracyte Inc (VCYT), with institutional investors hold 105.92% of the company’s shares. The shares outstanding are 76.81M, and float is at 75.65M with Short Float at 4.62%. Institutions hold 105.05% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 7.79 million shares valued at $168.88 million. The investor’s holdings represent 10.4241 of the VCYT Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 7.5 million shares valued at $162.46 million to account for 10.0281 of the shares outstanding. The other top investors are WELLINGTON MANAGEMENT GROUP LLP which holds 6.88 million shares representing 9.1977 and valued at over $149.01 million, while ARK INVESTMENT MANAGEMENT LLC holds 9.1082 of the shares totaling 6.81 million with a market value of $147.56 million.
Veracyte Inc (VCYT) Insider Activity
The most recent transaction is an insider sale by JONES EVAN/ FA, the company’s Director. SEC filings show that JONES EVAN/ FA sold 5,173 shares of the company’s common stock on Sep 19 ’24 at a price of $35.23 per share for a total of $0.18 million. Following the sale, the insider now owns 0.0 shares.
Veracyte Inc disclosed in a document filed with the SEC on Sep 04 ’24 that Leite John (Chief Commercial Officer-CLIA) sold a total of 5,479 shares of the company’s common stock. The trade occurred on Sep 04 ’24 and was made at $29.78 per share for $0.16 million. Following the transaction, the insider now directly holds 76174.0 shares of the VCYT stock.
Still, SEC filings show that on Sep 04 ’24, JOHN LEITE (Officer) Proposed Sale 5,479 shares at an average price of $30.29 for $0.17 million. The insider now directly holds shares of Veracyte Inc (VCYT).
